Print Page   |   Sign In   |   Register
Companies: Entia Biosciences Inc. (ERGO)

Company Profile

Description

Entia develops patented, pharmaceutical-grade organic compounds, including one known as ErgoD2. Entia believes that ErgoD2 improves iron homeostasis and mitigates iron-related disorders presenting in anemia, chronic kidney disease and select neurodegenerative diseases. Entia's goal is to clinically validate and commercialize ErgoD2 through the prescription Medical Food and OTC Supplement channels. 

Contact Information

  • 13565 SW Tualatin-Sherwood Road
  • Suite 800
  • Sherwood, OR 97140

 

Financial Reporting/Disclosure

Reporting Status U.S. Reporting: SEC Reporting
Audited Financials Audited
Latest Report Dec 31, 2016 10-K
CIK 0001408299
Fiscal Year End 12/31
OTC Marketplace Pink No Information

Profile Data

SIC - Industry Classification 2833 - Medicinal and botanicals
Incorporated In: NV, USA
Year of Inc. 2007
Employees Not Available

Company Officers/Contacts

Marvin S. Hausman, M.D. Chief Scientific Officer
Carl J. Johnson President, CEO
Timothy A. Timmins EVP, COO, CFO

Company Directors

Marvin S. Hausman, M.D. Chairman
Carl J. Johnson
Elliot L. Shelton

Service Providers

Accounting/Auditing Firm
Peterson Sullivan LLP
601 Union St.
Suite 2300
Seattle,WA,98101
United States

Securities Counsel Investor Relations Firm

Not Available

Company History

  • Formerly=Total Nutraceutical Solutions until 2-2012
  • Formerly=Generic Marketing Services, Inc. until 10-2008
 

 
Community Search
Sign In